Chronic Kidney Disease-Mineral Bone Disorder in Diabetes Mellitus Patients

Open access

Chronic Kidney Disease-Mineral Bone Disorder in Diabetes Mellitus Patients

Diabetes mellitus (DM) and chronic kidney disease (CKD) are two diseases with increasing prevalence and adverse outcomes that represent an international health problem. Chronic kidney disease- mineral and bone disorder (CKD-MBD) is defined as a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following: abnormalities of calcium, phosphorus, PTH, or vitamin D metabolism; abnormalities in bone turnover, mineralization, volume, linear growth, or strength and vascular or other soft-tissue calcification. Disturbances in mineral and bone metabolism are prevalent in CKD and are an important cause of decreased quality of life, cardiovascular morbidity and mortality; these disturbances settle in earlier and have a more severe evolution in DM patients.

Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 298(17): 2038-2047, 2007.

Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462.293 adults in Taiwan. Lancet 371(9631): 2173-2182, 2008.

Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.

Foley RN, Parfey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl 3): S112-S119, 1998.

Renal Romanian Registry: Annual Report of Renal Romanian Registry 2010. Ministery of Health-Clinical Nephrology Hospital "Dr Carol Davila", Bucuresti, Romania, 2011.

Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 16: 101-105, 2003.

Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004.

Diabetes atlas. Available from www.eatlas.idf.org/prevalence

Wild S, Roglic G, Green A et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-53, 2004.

Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.

ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2009. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2011.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney International 76 (Suppl 113): S1-S130, 2009.

Yoshiko Y, Wang H, Minamizaki T, et al. Mineralized tissue cells are a principal source of FGF23. Bone 40: 1565-1573, 2007.

Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130(3): 456-469, 2007.

Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007.

London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal diseases: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003.

Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71: 438-441, 2007.

Chue CD, Edwards NC, Davis LJ, et al. Serum Phosphate But Not Pulse Wave Velocity Predicts Decline in Renal Function in Patients With Early Chronic Kidney Disease, Nephrol Dial Transplant 26(8): 2576-2582, 2011.

Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005.

Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med 79: 571, 1985.

LeRoith BD, Taylor SJ, Olesky JO. Diabetes mellitus: a fundamental and clinical text, Lippincott Williams & Wilkins, 2004.

Langman CB, Cannata-Andia JB. Calcium in Chronic Kidney Disease: Myths and Realities, CJASN 5, Supplement 1: S1-S2, 2010.

Ribeiro S, Ramos A, Bandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism, Nephrol Dial Transplant 13: 2037-2040, 1998.

A. G. Pittas, J. Lau, F. Hu, et al. The Role of Vitamin D and Calcium in type 2 diabetes. A systematic Review and Meta-Analysis, Journal of Clinical Endocrinology & Metabolism (92) 6: 2017-2029, 2007.

Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 3(5):1535-1541, 2008.

Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol 3(5):1555-1560, 2008.

Zhang Z, Sun L, Wang Y, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 73: 163-171, 2008.

Gravellone L, Rizzo MA, Martina V, et al. Vitamin D receptor activators and clinical outcome in chronic kidney disease. Int J Nephol 2011: 419-524, 2011.

Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis, J Clin Endocrinol Metab 96(7): 1931-1942, 2011.

Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 52(2): 249-255, 2008.

Potts JT, Kronenberg H, Rosenblatt M. Parathyroid hormone: chemistry, biosynthesis, and mode of action. Adv. Protein Chem 35: 323-396, 1982.

Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61: 91-104, 2010.

Barrat J, Harris K, Topham P. Oxford desk reference nephrology, Oxford University Press 432-435, 2009.

Sambrook PN, Chen JS, March LM, et al. Serum Parathyroid Hormone Is Associated with Increased Mortality Independent of 25-Hydroxy Vitamin D Status, Bone Mass, and Renal Function in the Frail and Very Old: A Cohort Study, The Journal of Clinical Endocrinology & Metabolism (89) 11: 5477-5481, 2004.

Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16: 2205-2215, 2005.

Wesseling-Perry K. FGF-23 in bone biology, Pediatr Nephrol 25: 603-608, 2010.

Jüppner H. Phosphate and FGF-23. Kidney Int 79 (Suppl 121): S24-S27, 2011.

Yoshiko Y, Wang H, Minamizaki T, et al. Mineralized tissue cells are a principal source of FGF23. Bone 40: 1565-1573, 2007.

Tsuji K, Maeda T, Kawane T, et al. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1,25-dihydroxyvitamin D(3) synthesis in leptin-deficient mice. J Bone Miner Res (8): 1711-1723, 2010.

Mirza MAI, Alsio J, Hammarstedt A, et al. Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals Arterioscler Thromb Vasc Biol 31: 219-227, 2011.

Titan SM, Zatz R, Graciolli FG, et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 6(2): 241-247, 2011.

Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing, Nature 390 (6655): 45-51, 1997.

Kuro-o M. Phosphate and Klotho. Kidney Int 79 (Suppl 121): S20-S23, 2011.

Cheng MF, Chen LJ, Cheng JT. Decrease of Klotho in the Kidney of Streptozotocin-Induced Diabetic Rats, Journal of Biomedicine and Biotechnology Article ID 513853, 7 pages doi:10.1155/2010/513853, 2010.

O'Rouke RA, Brundage BH, Froelicher VF et al. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 102: 126-140, 2000.

Lindroos M, Kupari M, Heikkila J, et al. Prevalence of abnormal valve abnormalities in the elderly: An echographic study of a random population sample, J Am Coll Cardiol 21: 1220-1225, 1993.

Lanzer P. Monckeberg media calcinosis, Z Kardiol 87: 586-593, 1998.

Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor of all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study, J Am Soc Nephrol 14: 159-168, 2003.

Masse PG, Pacifique MB, Tranchant CC et al. Bone Metabolic Abnormalities Associated with Well-Controlled Type 1 Diabetes (IDDM) in Young Adult Women: A Disease Complication Often Ignored or Neglected. J Am Coll Nutr, 29(4): 419-429, 2010.

Romanian Journal of Diabetes Nutrition and Metabolic Diseases

The Journal of Romanian Society of Diabetes Nutrition and Metabolic Diseases

Journal Information


CiteScore 2018: 0.19

SCImago Journal Rank (SJR) 2018: 0.128
Source Normalized Impact per Paper (SNIP) 2018: 0.229

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1140 1081 30
PDF Downloads 1283 1271 23